Biodefense-related Research UMDNJ-New Jersey Medical School Nancy Connell, Ph.D. Director, UMDNJ Center for Biodefense Vice-chair for Research Department.

Slides:

Advertisements

Similar presentations

Biodefense A Bad Idea whose Time has Come David Ozonoff, MD, MPH Boston University School of Public Health MIT Seminar series on Biosecurity Cambridge,

Advertisements

Regional Centers of Excellence Academic defense against bioterrorism.

Highly containment laboratory in the National Institute of Infectious Diseases, Tokyo, Japan: activities, circumstances, and future challenges Masayuki.

Bruce A. Luxon, Ph.D. Director, Biomedical Informatics Institute for Translational Science Professor, Dept. of Biochemistry and Molecular Biology University.

Bioterrorism: Changing Priorities in Medical Training and Research Richard Coico Professor and Chairman Department of Microbiology & Immunology City University.

Division of Bacterial, Parasitic and Allergenic Products Jay E. Slater, MD Director, DBPAP 25 October 2013.

An Overview of Princeton’s Program on Science and Global Security Biodefense Activities Laura H. Kahn, MD, MPH, MPP Research Staff Program on Science and.

Principles and Practices of Biosafety Environmental Health and Safety San Diego State University.

Medical Diagnostics NIAID Funding Opportunities Maria Y. Giovanni, Ph.D. Assistant Director for Microbial Genomics and Advanced Technologies National Institute.

NIAID Bioinformatics Resource Centers Valentina Di Francesco Bioinformatics Program Director Microbial Genomics Program, DMID.

Training Programs in the Graduate School of Biomedical Sciences Newark Division.

The Select Agent Laboratory: at the intersection of research, preparedness and safety Nancy Connell,PhD Professor and Vice-chair for Research Department.

Domestic Preparedness: UMDNJ’s Role in Homeland Security Brendan McCluskey Deputy Director UMDNJ Center for BioDefense.

CBER Regulatory Laboratory Planning & Preparedness for SARS-related Biologics Products Kathryn M. Carbone MD Associate Director for Research, Acting, Center.

Center for Biologics Evaluation and Research Applying Regulatory Science to Advance Development of Innovative, Safe and Effective Biologic Products Carolyn.

Overview of Terrorism Research at the CDC Dixie E. Snider, M.D., MPH. Associate Director for Science Presented at 2003 Medical Research Summit March 6,

Preparing for Bioemergencies

U.S. Department of Defense Drug and Vaccine Development

Leslie W Kennedy Director RUTGERS Newark. Sponsored by the Rutgers School of Criminal Justice, Center for Global Change and Governance, College of Nursing.

Coming Soon... Mandatory Biosafety Training David W. Emery, Ph.D. Research Associate Professor of Medicine & Chair, Institutional Biosafety Committee On.

Center for Biologics Evaluation and Research FDA Overview Site Visit Carolyn A. Wilson, Ph.D. Associate Director for Research.

New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research.

What will be studied? What are the risks? Part II October 1, 2007 National Emerging Infectious Diseases Laboratories.

THE ROLE OF OIE COLLABORATING CENTRES IN STRENGTHENING OF VETERINARY SERVICES Center for Animal Health and Food Safety :: Global Initiative for Food Systems.

NERCE / BEID New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research.

Vice Chancellor for RESEARCH Office of the Global Health is America’s Health and National Security Samuel L. Stanley, Jr., M.D. Paul Rogers Global Health.

School of Medicine Shared Resource Facilities The School of Medicine provides direct support and oversight to 21 SOM shared resource facilities. Their.

Public Health and Healthcare in Ontario A Made in Ontario Solution for Public Health and Healthcare Andrew Papadopoulos Director, School of Occupational.

Division of Emerging and Transfusion Transmitted Diseases Bioterrorism Preparedness Initiatives Hira L. Nakhasi, Ph.D.

Bioterrorism MLAB 2434: Microiology Keri Brophy-Martinez.

Biosafety and the Southeast Asian Clinical Infectious Diseases Network (SEAICRN) Rogier van Doorn Clinical Microbiologist Wellcome Trust Major Overseas.

Hans Wolf-Watz, professor, UCMR, MIMS, Department of Microbiology, Umeå University, Sweden, Antibiotic resistance a new.

Germs Go Global Why Emerging Infectious Diseases Are a Threat to America Jeff Levi, PhD Executive Director Congressional Briefing April 17, 2009.

Johns Hopkins Technology Transfer 1 Translational Biomedical Research: Moving Discovery from Academic Centers to the Community Translational Biomedical.

Preparedness in Pennsylvania NGA Regional Bioterrorism Workshop- Boston, MA Michelle S. Davis, Deputy Secretary Health Planning & Assessment Bill Stevenson,

Emerging Diseases – Ready and Waiting Aileen J Plant Curtin University of Technology 19 October, 2004 Emerging Diseases: the human health perspective.

NIAID Commitment to Influenza Research and Preparedness F. Gray Handley Associate Director for International Research Affairs National Institute of Allergy.

Association of Health Care Journalists Preparing Communities For Pandemics Houston, Texas March 18, 2006 Georges C. Benjamin, MD, FACP Executive Director.

The Global Threat of Infectious Diseases Background 20 th Century Re-Emergence of Infectious Diseases - Newly recognized diseases - Known diseases -

US biosafety experiences during the last two decades: Lessons and achievements PETER PALESE MOUNT SINAI SCHOOL OF MEDICINE, New York BIOSECURITY, ISTANBUL,

Local Emergency Response to Biohazardous Incidents Dr. Elizabeth Whalen, MD Medical Director Albany County Health Department April 8, 2005 Northeast Biological.

Northwest Ohio Consortium for Public Health (NOCPH) Master of Public Health Degree Program Michael Bisesi, Ph.D. Director of NOCPH Chair and Professor,

“History is a set of lies agreed upon.” Napoleon Bonaparte.

Exploring Bioinformatics Careers. Place of Employment: Seattle Biomedical Research Institute Type of Work: Manages the DNA Sequencing “Core.” The Core.

FOR OFFICIAL USE ONLY The National Biodefense Analysis and Countermeasures Center The National Biodefense Analysis and Countermeasures Center Bernard C.

Public Health Issues Associated with Biological and Chemical Terrorism Scott Lillibridge, MD Director Bioterrorism Preparedness and Response Activity National.

Public Health Preparedness Summer Institute for Public Health Practice August 4, 2003.

Center for Biologics Evaluation and Research Carolyn A. Wilson, Ph.D. Associate Director for Research Applying Regulatory Science to Advance Development.

Emerging and Re-emerging Infectious Diseases Samantha Rosenthal, MPH, PhD Candidate.

Regional Centers of Excellence Program in Biodefense Samuel L. Stanley, Jr., M.D. Director, Midwest Regional Center of Excellence in Biodefense and Emerging.

Emergency Planning at Boston University Medical Center Peter Schneider Environmental Health and Safety Director Emergency Management Tools for Colleges.

ROC RETREAT February 3-4, 2005 Neil C. Olson, DVM, PhD Associate Dean For Research & Graduate Studies Director of CVM BioPark & Facilities Development.

The Integrated National Biodefense Portfolio Initiative “One-Portfolio” Chemical Biological Defense Acquisition Initiatives Forum (CBDAIF) May 6, 2009.

A. Discovery of New Genes related to Leishmania Pathogenesis and as Biomarkers of Attenuation Using a Genomic Microarray B. Multiplex PCR Microarray Assay.

Scientific Opportunities and Public Needs Resource Allocation and Priority Setting at the NIH.

OFFICE OF VACCINES RESEARCH AND REVIEW Center for Biologics Evaluation and Research Michael J. Brennan, Ph.D. Associate Director for Research OVRR Site.

Seasonal and Pandemic Influenza Research Activities National Vaccine Advisory Committee Meeting September 27, 2006 Barbara L. Mulach, Ph.D. National Institute.

Objectives  Define risk assessment as it relates to biosafety  Understand the risk assessment process and how to implement it  Discuss risk factors.

NIH Guidelines for Research Involving rDNA Molecules (NIH Guidelines) and Institutional Biosafety Committees.

روش استاندارد انتقال نمونه هاي عفوني براساس الزامات بين المللي.

The National Oversight of Bioscience Researches in Korea : Biosafety & Biosecurity WK Seong, CK Yoo, JK Lee, JB Ahn, and TJ Son Division of Biosafety Evaluation.

Stanford University Dual Use Research of Concern in the Life Sciences

Mission SUPPORT BASIC RESEARCH TO DEVELOP DRUGS, DIAGNOSTICS, AND VACCINES FOR EMERGING AND REEMERGING INFECTIONS AND BIODEFENSE. The Duke RBL supports.

Ch Epidemiology Microbiology.

Bioterrorism: A Changing World and What You Can Do

Transmission Pathways: Airborne Disease

Committee Task Statement (1)

A.L. BORTREE LECTURE SERIES

Overview of Terrorism Research at the CDC

Antimicrobials and Antimicrobial Resistance

Presentation transcript:

Biodefense-related Research UMDNJ-New Jersey Medical School Nancy Connell, Ph.D. Director, UMDNJ Center for Biodefense Vice-chair for Research Department of Medicine

UH-EMS Center for Biodefense 9-11 DoDfunding2000DoDfunding2001 DoDfunding2002,2003 Emerging Pathogens 1999 MOU With NYC Newark: MMRS WMD first- Responder training Incident Support And Operational Planning (2002) HHS funding (NJDoHSS) 2002, 2003 Mobilization of expertise Anthraxattacks MOU NJDoH “Public Health War College” Member:Domestic Preparedness Task Force - NJ BT annex Univ. Hospital plan: State model Renew MOU With NYC HRSA Funding 2003 NIH- Regional Center of Excellence in Biodefense Regional Biocontainment Laboratory ICPH (PHRI) INFORM

Biological Agent Research Capacity in Newark Center for Emerging and Re-emerging Pathogens (NJMS) International Center for Public Health –NJMS Microbiology –NJMS Nat’l TB Center –Public Health Research Inst

Biological agents Bacillus anthracis Yersinia pestis Burkholderia mallei Francisella tularensis Mycobacterium tuberculosis Hantaan virus Dengue virus Monkeypox Influenza virus SARS

Biological research areas Diagnostics –DNA microarrays –Molecular beacons Host response –Testing vaccine response (smallpox vaccine) –Infection models –Antibiotic resistance

DNA microarrays Infection by different organisms will turn on and off different patterns of genes in the host. Can we determine these patterns and use them for early diagnosis of infection?

DNA microarray analysis of the host response to infection NJMS/NJDS: Gallagher Alland Raveche Schutzer CBD: Jessica Mann Paula Trzop Carolina Sofer CAG (PHRI) Pat Soteropoulos Anthony Galante NJIT Michael Recce Virginie Airis avirulent vs virulent 37 uninfected vs virulent 80 uninfected vs virulent Total genes 44,

NIH Regional Center of Excellence in Biodefense and Emerging Pathogens Northeast Biodefense CenterNortheast Biodefense Center (among 8 of 14 applied) Consortium of 30 institutions: NY, NJ, CT investigators (P.I., Ian Lipkin [Columbia]) Commissioner Lacy: advisory board 3 New Jersey investigators on executive committee $45 million total award (5 yrs): $ 2 million to PHRI’s David Perlin as animal core director Vaccines, therapeutics, diagnostics, training Strong emphasis on global emerging infections (SARS, West Nile)

NIH Regional Biocontainment Laboratory Joint effort of NJMS and PHRI $21 million award with 1/3 match by UMDNJ 40,000 sq ft building adjacent to ICPH University Heights Science Park Jeannette Brummel, community liason Brings total Newark BSL space to 22,000 sq ft

NIH biodefense research priorities CAG (PHRI) Keck Center (Rutgers) Beacons (NJMS, PHRI) Arrays (NJMS) The RBL: NJMS, PHRI PHRI Northeast Biodefense Center